ID: ALA5185652

Max Phase: Preclinical

Molecular Formula: C32H50ClNO9

Molecular Weight: 628.20

Associated Items:

Representations

Canonical SMILES:  CC(=O)O[C@@H](C)/C=C\C(=O)N[C@@H]1C[C@H](C)[C@H](C/C=C(C)/C=C/[C@H]2O[C@H](CC(=O)OC(C)(C)C)C[C@@](O)(CCl)[C@@H]2O)O[C@@H]1C

Standard InChI:  InChI=1S/C32H50ClNO9/c1-19(10-13-27-30(38)32(39,18-33)17-24(42-27)16-29(37)43-31(6,7)8)9-12-26-20(2)15-25(22(4)41-26)34-28(36)14-11-21(3)40-23(5)35/h9-11,13-14,20-22,24-27,30,38-39H,12,15-18H2,1-8H3,(H,34,36)/b13-10+,14-11-,19-9+/t20-,21-,22+,24+,25+,26-,27+,30+,32+/m0/s1

Standard InChI Key:  UNQZBKKAIFNDAM-MRBWBORZSA-N

Associated Targets(Human)

MES-SA/Dx5 643 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MES-SA 905 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HEK-293T 167025 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 628.20Molecular Weight (Monoisotopic): 627.3174AlogP: 3.91#Rotatable Bonds: 11
Polar Surface Area: 140.62Molecular Species: NEUTRALHBA: 9HBD: 3
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.64CX Basic pKa: CX LogP: 2.96CX LogD: 2.96
Aromatic Rings: 0Heavy Atoms: 43QED Weighted: 0.13Np Likeness Score: 2.16

References

1. Ghosh AK, Mishevich JL, Jurica MS..  (2021)  Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors.,  84  (5.0): [PMID:33974423] [10.1021/acs.jnatprod.1c00100]

Source